BioMed Central | Articles which cite: The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C
Breast Cancer Res 2008, 10:R53
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL Proc Natl Acad Sci U S A 2009 Aug 18, 106:14016-21 [PubMed Central] [PubMed] [Related articles]
2.	Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer. Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C Neoplasia 2009 Oct, 11:987-1002 [PubMed Central] [PubMed] [Related articles]
3.	Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. Sung YM, Xu X, Sun J, Mueller D, Sentissi K, Johnson P, Urbach E, Seillier-Moiseiwitsch F, Johnson MD, Mueller SC PLoS One 2009, 4:e7445 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 5 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]